Current and historical daily PE Ratio for MDXG (
MiMedx Group Inc
) from 2008 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. MiMedx Group stock (MDXG) PE ratio as of Apr 27 2024 is 16.5.
More Details
MiMedx Group Inc (MDXG) PE Ratio (TTM) Chart
MiMedx Group Inc (MDXG) PE Ratio (TTM) Historical Data
View and export this data going back to 2008. Start your Free Trial
Total 1217
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| MiMedx Group PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-27 | 16.5 | 2024-02-23 | 21.6 |
| 2024-04-26 | 16.5 | 2024-02-22 | 21.5 |
| 2024-04-25 | 16.4 | 2024-02-21 | 21.2 |
| 2024-04-24 | 16.9 | 2024-02-20 | 21.2 |
| 2024-04-23 | 17.1 | 2024-02-16 | 21.2 |
| 2024-04-22 | 16.7 | 2024-02-15 | 21.7 |
| 2024-04-19 | 16.6 | 2024-02-14 | 21.2 |
| 2024-04-18 | 16.2 | 2024-02-13 | 20.9 |
| 2024-04-17 | 16.7 | 2024-02-12 | 21.8 |
| 2024-04-16 | 16.4 | 2024-02-09 | 20.9 |
| 2024-04-15 | 16.7 | 2024-02-08 | 20.5 |
| 2024-04-12 | 16.9 | 2024-02-07 | 20.4 |
| 2024-04-11 | 17.4 | 2024-02-06 | 20.5 |
| 2024-04-10 | 17.2 | 2024-02-05 | 20.2 |
| 2024-04-09 | 18.5 | 2024-02-02 | 20.4 |
| 2024-04-08 | 18.2 | 2024-02-01 | 20.7 |
| 2024-04-05 | 18.4 | 2024-01-31 | 20.4 |
| 2024-04-04 | 18.5 | 2024-01-30 | 20.9 |
| 2024-04-03 | 18.4 | 2024-01-29 | 21.9 |
| 2024-04-02 | 18.1 | 2024-01-26 | 21.2 |
| 2024-04-01 | 19.6 | 2024-01-25 | 21.3 |
| 2024-03-28 | 20.3 | 2024-01-24 | 21.3 |
| 2024-03-27 | 20.0 | 2024-01-23 | 22.1 |
| 2024-03-26 | 20.1 | 2024-01-22 | 22.3 |
| 2024-03-25 | 20.6 | 2024-01-19 | 21.4 |
| 2024-03-22 | 21.2 | 2024-01-18 | 21.7 |
| 2024-03-21 | 21.5 | 2024-01-17 | 22.0 |
| 2024-03-20 | 21.6 | 2024-01-16 | 21.3 |
| 2024-03-19 | 21.2 | 2024-01-12 | 21.2 |
| 2024-03-18 | 20.7 | 2024-01-11 | 21.2 |
| 2024-03-15 | 20.7 | 2024-01-10 | 21.3 |
| 2024-03-14 | 20.5 | 2024-01-09 | 21.1 |
| 2024-03-13 | 20.9 | 2024-01-08 | 21.6 |
| 2024-03-12 | 21.0 | 2024-01-05 | 20.5 |
| 2024-03-11 | 21.1 | 2024-01-04 | 20.4 |
| 2024-03-08 | 21.5 | 2024-01-03 | 20.5 |
| 2024-03-07 | 21.4 | 2024-01-02 | 20.7 |
| 2024-03-06 | 21.2 | 2023-12-29 | 23.1 |
| 2024-03-05 | 21.1 | 2023-12-28 | 23.4 |
| 2024-03-04 | 21.7 | 2023-12-27 | At Loss |
| 2024-03-01 | 22.7 | 2023-12-26 | At Loss |
| 2024-02-29 | 21.5 | 2023-12-22 | At Loss |
| 2024-02-28 | 21.6 | 2023-12-21 | At Loss |
| 2024-02-27 | 22.1 | 2023-12-20 | At Loss |
| 2024-02-26 | 21.7 | 2023-12-19 | At Loss |
MiMedx Group Inc (MDXG) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
MiMedx Group Inc
NAICS : 541713
SIC : 2834
ISIN : US6024961012
Description
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers